Skip to main content

Table 2 Healthcare resource utilization in a real-world type 2 diabetes mellitus population in the US in 2015, stratified by ASCVD status

From: Impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

Visit

Patients with type 2 diabetes mellitus

Non-ASCVD

N = 659,498 (54.8%)

ASCVD

N = 543,098 (45.2%)

Outpatient office visit

 Visits/patient, mean (SD)

5.6 (5.0)

9.1 (7.3)

 Patients with visits, n (%)

614,582 (93.2)

518,969 (95.6)

 1 to 4 visits

293,706 (44.5)

129,764 (23.9)

 5 to 8 visits

190,109 (28.8)

152,856 (28.2)

 9+ visits

130,767 (19.8)

236,349 (43.5)

Inpatient hospital visit

 Visits/patient, mean (SD)

0.1 (0.3)

0.2 (0.6)

 Patients with visits, n (%)

29,194 (4.4)

84,905 (15.6)

 1 visit

25,428 (3.9)

66,343 (12.2)

 2+ visits

3766 (0.6)

18,562 (3.4)

Emergency room, outpatienta

 Visits/patient, mean (SD)

0.2 (0.8)

0.6 (1.5)

 Patients with visits, n (%)

100,442 (15.2)

154,220 (28.4)

 1 visit

69,787 (10.6)

85,999 (15.8)

 2+ visits

30,655 (4.7)

68,221 (12.6)

Emergency room, inpatientb

 Visits/patient, mean (SD)

0.0 (0.1)

0.1 (0.2)

 Patients with visits, n (%)

5627 (0.9)

23,180 (4.3)

 1 visit

5274 (0.8)

20,898 (3.9)

 2+ visits

353 (0.1)

2282 (0.4)

Visits by specialty, n (%)

 Endocrinology

52,745 (8.0)

47,011 (8.7)

 Cardiology

73,286 (11.1)

217,159 (40.0)

  1. ASCVD Atherosclerotic cardiovascular disease
  2. aNot resulting in inpatient admission
  3. bResulting in inpatient admission